Antibacteria Drugs Growth Rate Forcast


antibacteria drug growth rate

Average growth rate of Antibacteria Drugs from 2014 to 2018 is CAGR of 0.2%.


Net value in 2014 is US 43.5 billion.


As antibacteria drugs has been in the forefront of medicine since the discovery of penicilin, the continue use of the drug for general medical treatment ensures a stable demand from the market.

Among the group, Beta-Lactams, sulfonamides and quinolones makes up the bulk of the usage. But due to increasing resistance of antibacteria drugs, macrolides and quinolones/fluoroquinolones will see increase usage as we move towards 2018.


Have a Free Insight into the viability of your business here

You can find more growth rate charts here